A study by Perrini et al. documented that CPAP treatment reduced serum concentration of MCP-1, while the levels remained unaltered in the non-OSA and subtherapeutic groups (p < 0.05) [25]. The gene discussed is CCL2; the disease is obstructive sleep apnea syndrome.